298|Antonio Doadrio
7.
De Cook y van der Bor M (2014) Obesogenic effects of endocrine disruptors, what
do we know from animal and human studies? Environ Int 70, 15-‐24.
8.
Desvergne B, Feige JN y Casals-‐Casas C. (2009) PPAR-‐mediated activity of
phthalates: A link to the obesity epidemic? Mol Cell Endocrinol. 304, 43–48.
9.
Diamanti-‐Kandarakis E, Palioura E, Kandarakis SA, Koutsilieris M (2010) The
impact of endocrine disruptors on endocrine targets. Horm Metab Res. 42, 543-‐52.
10.
Fava M (2000). Weight gain and antidepressants. J Clin Psychiatry. 61(Suppl 11),
37–41.
11.
García-‐Mayor RV, Larrañaga Vidal A, Docet Caamaño MF y Lafuente Giménez A
(2011) Disruptores endocrinos y obesidad: obesógenos. Endocrinología y
Nutrición pp 261-‐267.
12.
Gluckman PD, Hanson MA, Beedle AS, Raubenheimer D. (2008) Fetal and neonatal
pathways to obesity. Front Horm Res 36, 61–72.
13.
Grün F y Blumberg B (2009) Endocrine disrupters as obesogens. Mol Cell
Endocrinol. 304, 19–29.
14.
Grun F. (2010) Obesogens. Curr Opin Endocrinol Diabetes Obes. 17, 453–459.
15.
Grün F (2014) The obesongen tributylin. Vitam Horm 94, 277-‐325.
16.
Gluckman PD, Hanson MA, Beedle AS, Raubenheimer D. (2008) Fetal and neonatal
pathways to obesity. Front Horm Res 36, 61–72.
17.
Hoffmann IS, Alfieri AB, Cubeddu LX (2007) Effects of lifestyle changes and
metformin on salt sensitivity and nitric oxide metabolism in obese salt-‐sensitive
Hispanics. J Hum Hypertens. 21, 571-‐578.
18.
Inadera H, Shimomura A (2005) Environmental chemical tributyltin augments
adipocyte differentiation. Toxicol Lett. 159, 226–234.
19.
Janesick A y Blumberg B (2012) Obesogens, Stem Cells and the Developmental
Programming of Obesit. Int J Androl 35, 437-‐448.
20.
Kannan K (2014) Bisphenol A and cardiometabolic risk factors in obese children.
Sci Total Environ 1, 470-‐471
21.
Kesselmeier J, Staudt M (1999). Biogenic volatile organic compounds (VOC): an
overview on emission, physiology and ecology. Journal of Atmospheric Chemistry.
33, 23-‐88.
22.
Langer P. (2015) Global pollution by organochlorinated endocrine disruptors -‐
possible challenge for mankind at the onset of millennium. Endocr Regul. 49, 25-‐36
23.
Latini G Gallo F y Lughetti L (2010) Toxic environment and obesity pandemia: Is
there a relationship? Ital J Pediatr 36, 1-‐3.
24.
Panagiotakos DB, Chrysohoou C, Pitsavos C, Stefanadis C (2006). Association
between the prevalence of obesity and adherence to the Mediterranean diet: the
ATTICA study. Nutrition. 22, 449-‐456.
25.
Rocchini AP (2002) Obesity hypertension. Am J Hypertens. 15(2Pt2), 50-‐52.
